Source: New York Times
Data provided by Tricare Management Activity, the arm of the Department of Defense that manages health care services for the military, reveals that the number of Ritalin and Adderall prescriptions written for active-duty service members increased by nearly 1,000 percent in five years, to 32,000 from 3,000.
A recent medical study implies that soldiers exposed to elevated norepinephrine levels from taking stimulants like Ritalin and Adderall are also at risk of relapse when re-exposed to the initial stressor. And because the treatment of PTSD involves unlearning fear responses, soldiers exposed to stimulants during trauma could well be more resistant to treatment.
This is a Suspicious News Brief. Read more at the New York Times